LINC00355 Promotes Tumor Progression in HNSCC by Hindering MicroRNA-195-Mediated Suppression of HOXA10 Expression.

Lu S, Sun Z, Tang L, Chen L

Open source

DOI
10.1016/j.omtn.2019.11.002
Published
2020 Mar 6
Container
Molecular therapy. Nucleic acids
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtn.2019.11.002,
  title = {LINC00355 Promotes Tumor Progression in HNSCC by Hindering MicroRNA-195-Mediated Suppression of HOXA10 Expression.},
  author = {Lu S and Sun Z and Tang L and Chen L},
  year = {2020},
  journal = {Molecular therapy. Nucleic acids},
  doi = {10.1016/j.omtn.2019.11.002},
  url = {https://doi.org/10.1016/j.omtn.2019.11.002}
}

RIS

TY  - JOUR
TI  - LINC00355 Promotes Tumor Progression in HNSCC by Hindering MicroRNA-195-Mediated Suppression of HOXA10 Expression.
AU  - Lu S
AU  - Sun Z
AU  - Tang L
AU  - Chen L
PY  - 2020
JO  - Molecular therapy. Nucleic acids
DO  - 10.1016/j.omtn.2019.11.002
UR  - https://doi.org/10.1016/j.omtn.2019.11.002
ER  - 

APA

S, L., Z, S., L, T., & L, C. (2020). LINC00355 Promotes Tumor Progression in HNSCC by Hindering MicroRNA-195-Mediated Suppression of HOXA10 Expression.. Molecular therapy. Nucleic acids. https://doi.org/10.1016/j.omtn.2019.11.002

Source records